Showing results (1041-1050 of 2,992) with videos related to

Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.
Seminars in Thrombosis and Hemostasis|February 16, 2015
The new or non-vitamin K antagonist oral anticoagulants: what have we learned since their debutBrandon J McMahon, Hau C Kwaan
Seminars in Thrombosis and Hemostasis|February 16, 2015
Treatment of venous thromboembolism with new oral anticoagulants according to patient riskSam Schulman
Seminars in Thrombosis and Hemostasis|April 4, 2015
International survey on D-dimer test reporting: a call for standardizationGiuseppe Lippi, Armando Tripodi, Ana-Maria Simundic, et al.
Seminars in Thrombosis and Hemostasis|March 30, 2023
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the LiteratureAna Marco-Rico, Pascual Marco-Vera
Seminars in Thrombosis and Hemostasis|April 24, 2021
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)ThrombosisEmmanuel J Favaloro, Brandon Michael Henry, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis|April 14, 2021
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-AnalysisRoberta Parisi, Simona Costanzo, Augusto Di Castelnuovo, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2015
Complex history of the discovery and characterization of congenital factor X deficiencyAntonio Girolami, Elisabetta Cosi, Luisa Sambado, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2015
Diagnostics in venous thromboembolism: from origin to future prospectsGiuseppe Lippi, Elisa Danese, Emmanuel J Favaloro, et al.
Pageof 300